Literature DB >> 4670427

In vitro studies of tobramycin, an aminoglycoside antibiotic.

J Dienstag, H C Neu.   

Abstract

Tobramycin is an aminoglycoside antibiotic which has excellent antibacterial activity against Pseudomonas, Staphylococcus aureus, and many members of the Enterobacteriaceae. Most strains of Serratia, Providence, Streptococcus, and Diplococcus pneumoniae were resistant to concentrations of tobramycin which could be achieved in man. Tobramycin was effective against certain Pseudomonas strains resistant to gentamicin. The growth medium used to determine the inhibitory level of tobramycin had a significant effect upon the minimal inhibitory concentration. Calcium and magnesium ions inhibited the bactericidal effect of tobramycin. Tobramycin and carbenicillin acted in a synergistic manner. Ethylenediaminetetraacetic acid did not act in a synergistic manner with tobramycin. Broth-dilution susceptibility tests and disc-diffusion tests in agar (10-mug discs) showed excellent correlation except with Proteus strains.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4670427      PMCID: PMC444163          DOI: 10.1128/AAC.1.1.41

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Use of gentamicin in combinations with other antibiotics.

Authors:  C B Smith; P E Dans; J N Wilfert; M Finland
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

2.  Preclinical assessment of the antibacterial activity of nebramycin factor 6.

Authors:  D A Preston; W E Wick
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

3.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

4.  Resistance of Escherichia coli and Salmonella typhimurium to carbenicillin.

Authors:  H C Neu; H Swarz
Journal:  J Gen Microbiol       Date:  1969-11

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Preliminary studies with nebramycin factor 6.

Authors:  H R Black; R S Griffith
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

7.  Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation.

Authors:  W E Wick; J S Welles
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

8.  Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius.

Authors:  C E Higgins; R E Kastner
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967
  8 in total
  29 in total

1.  Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis.

Authors:  G Jaffe; B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

Review 2.  Antibacterial Drugs today: II.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

3.  Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin.

Authors:  R F D'amato; C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

4.  In vitro studies of BB-K8, a new aminoglycoside antibiotic.

Authors:  G P Bodey; D Stewart
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

5.  [Experimental investigations of the aqueous humor and blood serum of rabbits following injection of tobramycin].

Authors:  G Papapanos; A Petunis; X Karageorgiou
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1979-09

6.  In vitro susceptibility testing with tobramycin.

Authors:  S Shadomy; C Kirchoff
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

7.  Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Authors:  J A Waitz; E L Moss; C G Drube; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

8.  Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.

Authors:  I B Ducan; J L Penner
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

9.  In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

Review 10.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.